BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6104382)

  • 1. [Prevention of the initial forms of ischemic heart disease].
    Ianovskiĭ GV
    Vrach Delo; 1980 Apr; (4):32-4. PubMed ID: 6104382
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differential ambulatory treatment of patients with various forms of ischemic heart disease].
    Mazur NA
    Klin Med (Mosk); 1984 Oct; 62(10):34-9. PubMed ID: 6151015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Functional dynamics of ischemic heart disease patients with stable stenocardia as affected by drug treatment].
    Sidorenko BA; Lupanov VP; Kulikova TV; Nekrutman EA; Matveeva LS
    Klin Med (Mosk); 1984 Nov; 62(11):44-51. PubMed ID: 6151611
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with the prolonged use of beta-adrenergic blocking agents in the ambulatory treatment of patients with ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1980; 52(8):99-103. PubMed ID: 6114576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nitrates in therapy of coronary disease].
    Kaltenbach M; Becker HJ
    Dtsch Med Wochenschr; 1979 Dec; 104(49):1723-7. PubMed ID: 41700
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease].
    Bragina GI
    Klin Med (Mosk); 1981 Nov; 59(11):36-42. PubMed ID: 6119395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
    Ermilov LP; Kuleshova EV; Treshkur TV; Andreeva IV
    Klin Med (Mosk); 1980 Apr; 58(4):77-81. PubMed ID: 6103973
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombocytic hemostasis in the complex treatment of patients with ischemic heart disease].
    Khimenko PL; Nikitin AE
    Vrach Delo; 1985 May; (5):53-6. PubMed ID: 2861693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of calcium antagonists in the therapy of coronary heart disease].
    Meyer J
    Internist (Berl); 1983 Jul; 24(7):408-14. PubMed ID: 6136492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ambulatory treatment of chronic coronary insufficiency].
    Trifunović S
    Med Pregl; 1973; 26(9):355-7. PubMed ID: 4152544
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid peroxidation as an indicator of the effectiveness of treating patients with chronic ischemic heart disease using a helium-neon laser].
    Katel'nitskaia LI; Khodareva NK; Glushko AB
    Klin Med (Mosk); 1989 Jul; 67(7):37-9. PubMed ID: 2572722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of ischemic heart disease in ambulatory practice].
    Duck HJ; Trenckmann H; Fleischmann HJ; Neugebauer A; Schauer J
    Z Gesamte Inn Med; 1974 Nov; 29(22):932-6. PubMed ID: 4156817
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sympathetic-adrenal system in ischemic heart disease before and after obzidan treatment].
    Orlov VN; Chigrinova LS
    Klin Med (Mosk); 1981 Jun; 59(6):74-8. PubMed ID: 6116820
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drugs for the management of chronic ischemic heart disease].
    Klotzbach M
    Pharmazie; 1979 Aug; 34(8):487-90. PubMed ID: 43982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drugs in the coronary group (author's transl)].
    Hüllemann KD
    MMW Munch Med Wochenschr; 1980 Jun; 122(24):897-900. PubMed ID: 6104787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of the sympathomimetic activity of beta-adrenergic blockaders in the treatment of patients with chronic ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1983; 55(9):35-40. PubMed ID: 6138864
    [No Abstract]   [Full Text] [Related]  

  • 18. [Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998].
    Jenni D; Osterwalder R; Osswald S; Buser P; Pfisterer M
    Praxis (Bern 1994); 2001 Oct; 90(41):1759-65. PubMed ID: 11692790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials.
    Parker JD
    Eur Heart J; 1998 Aug; 19 Suppl I():I15-9. PubMed ID: 9743439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.